您的购物车当前为空
别名 TGN1412, TABO8, TAB-08
Theralizumab (TGN1412) 是一种抗靶向 CD28 的单克隆抗体,可直接刺激 T 细胞。Theralizumab 具有抗肿瘤活性,用于治疗 B 细胞慢性淋巴细胞白血病和类风湿性关节炎。

为众多的药物研发团队赋能,
让新药发现更简单!
Theralizumab (TGN1412) 是一种抗靶向 CD28 的单克隆抗体,可直接刺激 T 细胞。Theralizumab 具有抗肿瘤活性,用于治疗 B 细胞慢性淋巴细胞白血病和类风湿性关节炎。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,880 | In stock | |
| 5 mg | ¥ 6,570 | In stock | |
| 10 mg | ¥ 8,860 | In stock | |
| 25 mg | ¥ 12,900 | In stock | |
| 50 mg | ¥ 17,700 | In stock |
Theralizumab 相关产品
| 产品描述 | Theralizumab (TGN1412) is an anti-CD28-targeting monoclonal antibody that directly stimulates T cells. Theralizumab has antitumor activity and is used for the treatment of B-cell chronic lymphocytic leukemia and rheumatoid arthritis. |
| 别名 | TGN1412, TABO8, TAB-08 |
| CAS No. | 906068-56-2 |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容